Vilnius, Lithuania

Danguole Bartkeviciute

This inventor holds 1 USPTO granted patent. Top assignee: Tad Pharma Gmbh. Active years: 2006.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Danguole Bartkeviciute: Innovator in Yeast Biotechnology

Introduction

Danguole Bartkeviciute is a prominent inventor based in Vilnius, Lithuania. She has made significant contributions to the field of biotechnology, particularly in yeast research. Her innovative work has led to the development of a patent that enhances the understanding and application of yeast cells in various biotechnological processes.

Latest Patents

Danguole Bartkeviciute holds a patent for "Regulatory sequences and expression cassettes for yeasts, especially for Kluyveromyces." This invention relates to a DNA sequence that acts as a promoter in yeast cells. It includes an expression and optionally, a secretion system containing the DNA sequence, plasmids that incorporate this system, and host cells transformed with the DNA. The methods developed through this patent are aimed at producing proteins and polypeptides efficiently.

Career Highlights

Danguole is currently employed at Tad Pharma GmbH, where she continues to apply her expertise in yeast biotechnology. Her work at the company focuses on advancing biotechnological applications that can lead to significant improvements in various industries.

Collaborations

Danguole has collaborated with notable colleagues, including Dietmar Becher and Kestutis Sasnauskas. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.

Conclusion

Danguole Bartkeviciute is a trailblazer in yeast biotechnology, with a patent that showcases her innovative spirit and dedication to advancing scientific knowledge. Her contributions are paving the way for future developments in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…